| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | UNITED THERAPEUTICS | 712,186 | 122,806,000 | 11.18% | ||
| 2 | AKORN INC | 1,938,485 | 92,097,000 | 8.39% | ||
| 3 | HYPERION THERAPEUTICS INC | 1,901,930 | 87,299,000 | 7.95% | ||
| 4 | CARDIOVASCULAR SYS INC DEL COM | 2,192,500 | 85,595,000 | 7.79% | ||
| 5 | INSYS THERAPEUTICS INC NEW COM NEW | 1,359,247 | 79,013,000 | 7.19% | ||
| 6 | RETROPHIN INC COM | 3,107,710 | 74,461,000 | 6.78% | ||
| 7 | ANI PHARMACEUTICALS INC COM | 1,124,667 | 70,348,000 | 6.41% | ||
| 8 | ABBVIE INC | 1,177,900 | 68,954,000 | 6.28% | ||
| 9 | ORTHOFIX INTERNATIONAL NV | 1,580,218 | 56,714,000 | 5.16% | ||
| 10 | Anacor Pharmaceuticals Inc | 830,151 | 48,024,000 | 4.37% | ||
| 11 | ENANTA PHARMACEUTICALS INC COM | 1,552,962 | 47,552,000 | 4.33% | ||
| 12 | SUPERNUS PHARMACEUTICALS INC COM | 3,566,923 | 43,124,000 | 3.93% | ||
| 13 | PERNIX THERAPEUTICS HLDGS IN | 3,261,484 | 34,865,000 | 3.17% | ||
| 14 | HEALTHWAYS INC | 1,716,307 | 33,811,000 | 3.08% | ||
| 15 | EAGLE PHARMACEUTICALS INC COM | 735,922 | 30,828,000 | 2.81% | ||
| 16 | OSIRIS THERAPEUTICS INC NEW COM | 1,198,336 | 21,067,000 | 1.92% | ||
| 17 | CATALYST PHARMACEUTICALS INC | 4,849,870 | 21,000,000 | 1.91% | ||
| 18 | DERMA SCIENCES INC COM PAR .01 | 1,632,627 | 13,828,000 | 1.26% | ||
| 19 | EPIRUS BIOPHARMA | 1,523,773 | 13,638,000 | 1.24% | ||
| 20 | PACIFIC BIOSCIENCES CALIF IN | 2,002,971 | 11,697,000 | 1.07% | ||
| 21 | PROTALIX BIOTHERAPEUTICS INC | 5,643,750 | 10,046,000 | 0.91% | ||
| 22 | ADMA BIOLOGICS, INC. | 986,507 | 9,668,000 | 0.88% | ||
| 23 | VERICEL CORP | 2,352,940 | 8,706,000 | 0.79% | ||
| 24 | BIOTIME INC | 1,602,550 | 7,965,000 | 0.73% | ||
| 25 | MERUS LABS INTL INC NEW | 1,368,614 | 2,874,000 | 0.26% | ||
| 26 | VERACYTE INC | 235,860 | 1,717,000 | 0.16% | ||
| 27 | EHEALTH INC COM | 52,900 | 496,000 | 0.05% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001085146-15-001217, filed 2015.05.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
